Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
TIVO SOLUTIONS INC. (TIVO)
|
Add to portfolio |
|
|
|
| Price: |
$6.09
| | Metrics |
| OS: |
101.1
|
M
| |
6
|
% ROE
|
| Market cap: |
$616
|
M
| |
21
|
% ROIC
|
|
Net cash:
|
$342
|
M
| |
$3.39
|
per share
|
|
EV:
|
$273
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$67.3
|
M
| |
4.1
|
x EV/EBITDA
|
|
EBIT
|
$48.8
|
M
| |
5.6
|
x EV/EBIT
|
| EPS |
$0.24
| |
25.6
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 05/07/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds MINI, WLTW, GCAP and TIVO Shareholders About Its Ongoing Investigations |
| 04/30/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds MINI, TIVO, MEET, and DLPH Shareholders About Its Ongoing Investigations |
| 04/23/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds TIVO, MINI, MEET, and DLPH Shareholders About Its Ongoing Investigations |
| 04/17/2020 |
GN
| Engaged Capital Partners to Donate All Board Fees for Remainder of 2020 |
| 03/31/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds XPER, TIVO, POPE and WMGI Shareholders About Its Ongoing Investigations |
| 03/24/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds WMGI, XPER, TIVO, and RESI Shareholders About Its Ongoing Investigations |
| 03/23/2020 |
GN
| Rigrodsky & Long, P.A. Files Class Action Suit Against TiVo Corporation |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-31-16 | Jan-31-15 | Jan-31-14 | Jan-31-13 | Jan-31-12 | Jan-31-11 | Jan-31-10 | Jan-31-09 |
| Revenues | 489.6 | 451.5 | 406.3 | 303.9 | 238.2 | 219.6 | 238.5 | 250.2 |
| Revenue growth | 8.4% | 11.1% | 33.7% | 27.6% | 8.5% | -7.9% | -4.7% | -8.2% |
| Cost of goods sold | 196.5 | 177.8 | 171.3 | 141.5 | 118.4 | 128.4 | 127.5 | 114.6 |
| Gross profit | 293.1 | 273.7 | 234.9 | 162.4 | 119.8 | 91.2 | 111.0 | 135.5 |
| Gross margin | 59.9% | 60.6% | 57.8% | 53.5% | 50.3% | 41.5% | 46.5% | 54.2% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 46.7 | 42.1 | 39.0 | 30.4 | 26.4 | 27.6 | 23.3 | 24.9 |
| Research and development | 107.8 | 102.2 | 106.9 | 115.1 | 110.4 | 81.6 | 63.0 | 62.1 |
| General and administrative | 59.8 | 59.5 | 77.3 | 87.1 | 96.5 | 59.5 | 44.8 | 42.9 |
| EBITA | 64.7 | 69.2 | 111.6 | 3.2 | 112.0 | -83.0 | -25.2 | 87.4 |
| EBITA margin | 13.2% | 15.3% | 27.5% | 1.1% | 47.0% | -37.8% | -10.6% | 34.9% |
| Amortization of intangibles | 10.3 | 8.2 | 4.3 | 3.5 | 2.7 | 2.6 | | |
| EBIT | 54.4 | 61.0 | 107.3 | -0.3 | 109.3 | -85.6 | -25.2 | 87.4 |
| EBIT margin | 11.1% | 13.5% | 26.4% | -0.1% | 45.9% | -39.0% | -10.6% | 34.9% |
| Pre-tax income | 38.0 | 53.2 | 103.9 | -4.2 | 103.0 | -84.3 | -24.1 | 105.4 |
| Income taxes | 16.3 | 22.4 | -167.9 | 1.0 | 0.8 | 0.2 | -1.0 | 1.3 |
| Tax rate | 42.9% | 42.1% | | | 0.8% | | 4.3% | 1.3% |
| Net income | 21.7 | 30.8 | 271.8 | -5.3 | 102.2 | -84.5 | -23.0 | 104.1 |
| Net margin | 4.4% | 6.8% | 66.9% | -1.7% | 42.9% | -38.5% | -9.7% | 41.6% |
| |
| Diluted EPS | $0.23 | $0.24 | $1.96 | ($0.04) | $0.75 | ($0.74) | ($0.22) | $1.04 |
| Shares outstanding (diluted) | 95.9 | 126.8 | 138.8 | 119.4 | 136.3 | 113.5 | 106.2 | 100.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|